Radiotherapy in the Region of the Head and Neck and the Consequential Changes in Normal Tissues.
- Author:
Tae Jin HAN
1
Author Information
1. Department of Radiation Oncology, Kangdong Sacred Heart Hospital, College of Medicine, University of Hallym, Seoul, Korea. hantz@hallym.or.kr
- Publication Type:Review
- Keywords:
Head and neck cancer;
Radiotherapy;
Toxicity;
Quality of life
- MeSH:
Atrophy;
Deglutition;
Deglutition Disorders;
Fibrosis;
Hand;
Head and Neck Neoplasms;
Head*;
Humans;
Inflammation;
Neck*;
Quality of Life;
Radiotherapy*;
Saliva;
Stomatitis;
Survivors;
Xerostomia
- From:
Journal of the Korean Dysphagia Society
2018;8(2):57-66
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Radiotherapy is a crucial non-surgical modality for head and neck cancer. With increasing radiation dose, the possibility of tumor control increases but the probability of toxicity to the surrounding normal tissue also increases. The subsequent changes in the normal tissues after radiotherapy can occur within a few minutes, or even several years. The early effects occur in rapidly proliferating tissue and tend to cause inflammation and are usually reversible. The late effects occur in more slowly proliferating tissues and the pathogenesis includes fibrosis, atrophy, and vascular damage. The early and late responses of the normal tissue can be dose-limiting factors in radiotherapy for head and neck cancer, affecting the therapeutic efficacy and quality of life of cancer survivors. Radiation-induced oral mucositis is the major limiting acute toxicity of radiotherapy for head and neck cancers and can lead to treatment interruption and suboptimal disease control. On the other hand, the most problematic late toxicities in the region of the head and neck are decreased secretion of saliva and dysfunction in swallowing. This review investigated the pathophysiology of radiation-induced toxicity: oral mucositis, xerostomia and dysphagia.
